Houssein Safa
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Polyomavirus and related diseases
- Viral-associated cancers and disorders
- Transplantation top 10%
Papers in
- Co-authors
- Adi Diab (7 shared papers)Heather Lin (3 shared papers)Noha Abdel‐Wahab (5 shared papers)Daniel H. Johnson (3 shared papers)María E. Suarez‐Almazor (5 shared papers)Van Anh Trinh (3 shared papers)Michael K. Wong (2 shared papers)A. Osama Gaber (2 shared papers)
- Journals
- Journal for ImmunoTherapy of Cancer (3 papers)Urologic Clinics of North America (2 papers)JNCI Journal of the National Cancer Institute (1 paper)Expert Opinion on Pharmacotherapy (1 paper)Cancers (1 paper)
- Partner nations
- United StatesEgyptItaly
In The Last Decade
Houssein Safa
17 papers receiving 488 citations
Peers
Comparison fields: 5 of 51
- Oncology 308
- Transplantation 25
- Neurology 88
- Hepatology 27
- Genetics 32
Countries citing papers authored by Houssein Safa
This map shows the geographic impact of Houssein Safa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Houssein Safa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Houssein Safa more than expected).
Fields of papers citing papers by Houssein Safa
This network shows the impact of papers produced by Houssein Safa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Houssein Safa. The network helps show where Houssein Safa may publish in the future.
Co-authors
The 25 scholars most cited alongside Houssein Safa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 198 | |
| 2 | 2019 | 195 | |
| 3 | 2020 | 29 | |
| 4 | 2023 | 15 | |
| 5 | 2024 | 12 | |
| 6 | 2025 | 6 | |
| 7 | 2021 | 5 | |
| 8 | 2022 | 4 | |
| 9 | 2019 | 4 | |
| 10 | 2023 | 4 | |
| 11 | 2020 | 4 | |
| 12 | 2019 | 3 | |
| 13 | 2020 | 3 | |
| 14 | 2024 | 2 | |
| 15 | 2024 | 2 | |
| 16 | 2022 | 2 | |
| 17 | 2024 | 1 |
About Houssein Safa
Houssein Safa is a scholar working on Oncology, Surgery, Cancer Research, Epidemiology and Molecular Biology, having authored 17 papers that have together received 489 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Genital Health and Disease (5 papers), Cancer Genomics and Diagnostics (3 papers), CAR-T cell therapy research (3 papers), Cervical Cancer and HPV Research (2 papers), Colorectal and Anal Carcinomas (2 papers), Urologic and reproductive health conditions (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Oncology (308 citations), Transplantation (25 citations), Neurology (88 citations), Hepatology (27 citations) and Genetics (32 citations). Houssein Safa has collaborated with scholars based in United States, Egypt and Italy. Frequent co-authors include Adi Diab, Heather Lin, Noha Abdel‐Wahab, Daniel H. Johnson, María E. Suarez‐Almazor, Van Anh Trinh, Michael K. Wong, A. Osama Gaber, Chrystia M. Zobniw and Ala Abudayyeh. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Urologic Clinics of North America, JNCI Journal of the National Cancer Institute, Expert Opinion on Pharmacotherapy and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.